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Abstract 
Background: Bacillus anthracis, which causes anthrax in humans and animals, is enzootic in parts of the U.S. state 
of Texas where cases are typically reported in animals annually. The gamma phage lysis assay is a common diagnos-
tic method for identification of B. anthracis and is based on the bacterium’s susceptibility to lysis. This test has been 
shown to be 97% specific for B. anthracis, as a small number of strains of other Bacillus spp. are known to be suscep-
tible. In this study, we evaluated the performance of a combination of B. anthracis diagnostic assays on 700 aerobic, 
spore-forming isolates recovered from soil collected in Texas. These assays include phenotypic descriptions, gamma 
phage susceptibility, and real-time polymerase chain reaction specific for B. anthracis. Gamma phage-susceptible 
isolates were also tested using cell wall and capsule direct fluorescent-antibody assays specific for B. anthracis. Gamma 
phage-susceptible isolates that were ruled out as B. anthracis were identified by 16S rRNA gene sequencing.
Findings: We identified 29 gamma phage-susceptible isolates. One was confirmed as B. anthracis, while the other 
28 isolates were ruled out for B. anthracis by the other diagnostic tests. Using 16S rRNA gene sequencing results, we 
identified these isolates as members of the B. cereus group, Bacillus sp. (not within B. cereus group), Lysinibacillus spp., 
and Solibacillus silvestris. Based on these results, we report a specificity of 96% for gamma phage lysis as a diagnostic 
test for B. anthracis, and identified susceptible isolates outside the Bacillus genus.
Conclusions: In this study we found gamma phage susceptibility to be consistent with previously reported results. 
However, we identified non-B. anthracis environmental isolates (including isolates from genera other than Bacil-
lus) that are susceptible to gamma phage lysis. To date, susceptibility to gamma phage lysis has not been reported 
in genera other than Bacillus. Though these isolates are not of clinical origin, description of unexpected positives is 
important, especially as new diagnostic assays for B. anthracis are being developed based on gamma phage lysis or 
gamma phage proteins.
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Background
Bacillus anthracis, the cause of anthrax in humans and 
animals, is an endospore-forming bacterium that can 
persist in the environment for many years. In the U.S., 
B. anthracis infections in animals occur in states that 
are enzootic for the disease, such as Texas, North and 
South Dakota, and Minnesota [1–5]. Anthrax outbreaks 
have occurred annually in livestock and wild game in 
Texas for the past decade. Outbreaks pertinent to this 
study include an outbreak in a cattle herd in July 2007 on 
a ranch north of San Angelo, Texas, and an outbreak in 
horses on an adjacent ranch in August 2007 [6, 7].
Identification of B. anthracis is commonly based on col-
ony morphology (including hemolysis), capsule produc-
tion, detection of virulence plasmids (pXO1 and pXO2) 
by real-time PCR, and susceptibility to lysis by gamma 
phage [8–10]. The gamma phage assay is widely used as 
a diagnostic test for B. anthracis in many laboratories 
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due to ease and low cost of use. Recently, several stud-
ies have used gamma phage binding and lytic activity as 
the basis for newer diagnostic assays, such as using engi-
neered phage for bioluminescent detection [11–16]. The 
specificity and sensitivity of gamma phage has been pre-
viously documented, and although the specificity for B. 
anthracis is very high (97%), a small number of isolates 
of close relatives, including examples of Bacillus cereus 
and Bacillus thuringiensis, are susceptible [9, 17]. In this 
study, we evaluated the specificity of the gamma phage 
assay in conjunction with other diagnostic tests to screen 
700 spore-forming Texas soil isolates for identification of 
B. anthracis.
Methods
Texas soil collection and processing
Core soil samples were collected in September 2007 
from two sites in Texas in or near the municipalities of 
Schertz and San Angelo. Schertz was chosen due to the 
previous identification of pathogenic B. cereus isolates 
(two clinical, one environmental) harboring B. anthracis 
toxin and/or capsule genes that were associated with fatal 
pneumonias in metal workers from the area in 2003 [18]. 
San Angelo was chosen due to the recent anthrax out-
breaks in cattle and horses mentioned above [6, 7]. Ster-
ile 50 mL conical tubes were uncapped and twisted down 
into the soil to a depth of approximately 2.5–3.0 cm. The 
tubes containing the core samples were then re-capped 
and wrapped in parafilm. Samples were shipped at ambi-
ent temperature and subsequently stored at – 30 °C until 
processing.
Three samples were selected for testing (one from 
Schertz and two from San Angelo), and 2–3 bacterial 
extractions were performed on each sample. For each 
extraction, approximately 3.5  g of soil were transferred 
to a sterile 15  mL conical tube. The soil was saturated 
with phosphate-buffered saline containing 0.3% Tween 
20 (PBST) and an additional 1.0 mL of PBST was added, 
then the sample was vortexed at high speed for 1–3 min. 
To select for spore-forming bacteria, the samples were 
heat shocked at 65  °C for 30  min and allowed to settle. 
The supernatant was transferred to a 2.0  mL screw-cap 
tube, and briefly centrifuged at 2000–3000 rpm. The fol-
lowing amounts were plated to produce 20–50 colonies/
plate: 100  µL of the undiluted supernatant was plated 
onto PLET (polymyxin, lysozyme, ethylenediaminetet-
raacetic acid, thallium acetate) agar plates, a selective 
medium for B. anthracis [19], while 100  µL aliquots of 
a 1:20 dilution were plated onto 10 trypticase soy agar 
plates containing 5% sheep blood (SBA). Both PLET and 
SBA plates were incubated overnight at 37 °C. Seven hun-
dred random single colonies were picked and streaked 
to SBA for isolation. Isolates were then streaked onto 
sporulation medium (agar containing tryptone, peptone, 
yeast extract, and manganous chloride) and incubated at 
30  °C for 5–7  days. Spores were harvested in 25% glyc-
erol in deionized water and stored as spore suspensions 
at – 70 °C.
Isolate screening and identification
Phenotypic characteristics, including hemolysis and 
colony morphology on SBA (see Additional file  1), and 
gamma phage susceptibility were recorded for all iso-
lates. Gamma phage testing was performed as previ-
ously described [9], with susceptibility defined as any 
amount of lysis or reduced growth where gamma phage 
was applied. Cell lysates containing DNA were prepared 
as previously described [8], and were tested using the 
Laboratory Response Network’s real-time PCR assay for 
detection of the B. anthracis chromosome, and of viru-
lence plasmids pXO1 and pXO2 genes (pagA and capB, 
respectively) [8, 17]. For isolates exhibiting susceptibil-
ity to gamma phage lysis, the cell wall (CW) and capsule 
(CAP) direct fluorescent antibody (DFA) assays were also 
performed as previously described [10]. Gamma phage-
susceptible isolates that were ruled-out for B. anthra-
cis using the tests above were identified by 16S rRNA 
gene sequencing as previously described [20]. For iso-
lates that produced readable sequences, the sequences 
were compared to published type strain sequences 
(when applicable) in NCBI’s GenBank database using 
BLAST, using a sequence similarity of 99–100%. The 16s 
rRNA sequences of isolates 2008723338, 2008723339, 
2008723400, 2008723423, 200872372 and 2008723476 
were deposited in GenBank with Accession Numbers 
KT254134, KT254135, KT254136, KT254137, KT254138 
and KT254139, respectively. Isolates identified as belong-
ing to the B. cereus group were further typed by multi 
locus sequence typing (MLST), performed as previously 
described [21].
Table 1 Results of gamma phage susceptibility testing
a Final identification based on B. anthracis real-time PCR, 16S rRNA gene 
sequencing, and CW- and CAP-DFA
b Number of true positives
c Number of false positives
d Number of false negatives
e Number of true negatives
Final  identificationa Totals
B. anthracis Other spp.
Gamma phage lysis
 Positive 1b 28c 29
 Negative 0d 671e 671
 Totals 1 699 700
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Fig. 1 Neighbor-joining dendrogram of 16S rRNA gene sequences, showing the relationship of isolates and representative isolates from each 
grouping (shown in bold) to a panel of related bacteria. Bootstrap values (based on 1000 replications) are given as percentages at branch nodes. 
Brevibacillus brevis is used as an outgroup for this analysis
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Findings
Twenty-nine of the 700 isolates were susceptible to 
gamma phage lysis, with 20 exhibiting hemolysis on SBA 
and with variable colony morphologies (see Additional 
files 1 and 2). One isolate was identified as B. anthra-
cis (PCR positive for all targets, nonhemolytic, gamma 
phage-susceptible, and positive by CW- and CAP-DFA 
assays). The other 28 isolates were negative for all three B. 
anthracis PCR markers, including virulence genes pagA 
and capB, and all were negative for the CW-DFA and 
CAP-DFA assays except for isolate 2008723634, which 
was weakly positive for the CW-DFA assay. Based on 
the combined results of these tests, 28 of the 29 gamma 
phage-susceptible isolates were ruled out as B. anthracis. 
We calculated the specificity of the gamma phage test as 
96% by dividing the number of true negatives by the sum 
of the number of true negatives plus the number of false 
positives, multiplied by 100 (see Table  1). Twenty-five 
of these 28 isolates produced readable 16S rRNA gene 
sequences, and were identified as follows: six Lysinibacil-
lus spp., one Bacillus sp., one Solibacillus silvestris, and 
17 isolates could only be identified as “B. cereus group 
members” due to the inability to distinguish members of 
the B. cereus group based on 16S gene sequencing. Rep-
resentative isolates from each group are shown in Fig. 1. 
The 16S sequence data was not analyzed for three isolates 
due to failure to amplify.
Multi locus sequence typing was performed on all of 
the 17 B. cereus group isolates, however, only eight iso-
lates produced usable gene segments for all seven alleles. 
All eight isolates were different sequence types (ST), and 
therefore, not multiple isolations of a single clone. Seven 
of the eight isolates were new STs, and were compared 
with other previously identified gamma phage-suscep-
tible B. cereus isolates, as well as other B. cereus-group 
STs (Fig.  2) [17, 21]. None of the eight B. cereus group 
isolates identified cluster with previously identified 
gamma phage-susceptible isolates (ST-129, ST-130, or 
ST-132), however six of the isolates from this study did 
cluster closely together (Fig.  2) [21]. The other two B. 
cereus group isolates (2008723644 and 2008723286) 
were identified as ST-502 or clustered nearest to ST-502, 
respectively.
Fig. 2 Relationships between B. cereus group member isolates of this 
study and select reference isolates using concatenated sequences 
from seven housekeeping alleles. Sequence types (STs) with previ-
ously identified gamma phage susceptible isolates are shown in bold, 
and isolates from this study with new STs are marked (asterisk). The 
tree was constructed using the neighbor joining method and percent 
bootstrap confidence levels were calculated using 1000 resamplings 
of the original data
◂
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In conclusion, the diagnostic tests used in this study 
showed high specificity (real-time PCR 100% and gamma 
phage 96%). Interestingly, despite reports of B. cereus 
isolates harboring pXO1 and pXO2 plasmids or some 
of their genes (pagA and capB), these markers were not 
detected in any of the 700 isolates, except for the single 
B. anthracis isolate [18, 22–24]. Though gamma phage 
susceptibility is considered specific for B. anthracis, rare 
false positives can occur due to the susceptibility of a few 
other species. To our knowledge, this is the first report 
of susceptible isolates outside the Bacillus genus. Though 
the isolates described in this study are of environmen-
tal origin rather than clinical, and are often thought of 
as contaminants in the clinical laboratory, most can be 
opportunistic pathogens [25]. Therefore, it is important 
to note their existence, especially when new diagnos-
tic methods are being developed using gamma phage or 
gamma phage proteins for the detection of B. anthracis in 
clinical or environmental samples [11–16].
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